UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines

Frontiers in immunology, 2018-04, Vol.9, p.557-557

Pranzatelli, Michael R

2018

Link zum Volltext

Verfügbarkeit prüfen

Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study

Frontiers in neurology, 2017-09, Vol.8, p.468-468

2017

Link zum Volltext

Verfügbarkeit prüfen

Elevated cerebrospinal fluid C-X-C motif chemokine 10: Commonalities in paraneoplastic neurological disorders

Annals of neurology, 2016-11, Vol.80 (5), p.792-793

Pranzatelli, Michael R.

2016

Link zum Volltext

Verfügbarkeit prüfen

BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy

Journal of neuroinflammation, 2013-01, Vol.10 (1), p.10-10, Article 806

2013

Link zum Volltext

Verfügbarkeit prüfen

B cell depletion therapy for new-onset opsoclonus-myoclonus

Movement disorders, 2010-01, Vol.25 (2), p.238-242

2010

Link zum Volltext

Verfügbarkeit prüfen

Response to Correspondence on “Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome”

Journal of Child Neurology, 2013-03, Vol.28 (3), p.417-418

2013

Link zum Volltext

Verfügbarkeit prüfen

Multifactorial analysis of opsoclonus‐myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children

Pediatric blood & cancer, 2018-08, Vol.65 (8), p.e27097-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping

Seminars in pediatric neurology, 2017-08, Vol.24 (3), p.229-239

2017

Link zum Volltext

Verfügbarkeit prüfen

Going with the flow: neuroinflammation

Developmental medicine and child neurology, 2011-09, Vol.53 (9), p.782-782

PRANZATELLI, MICHAEL R

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study

European journal of paediatric neurology, 2018-07, Vol.22 (4), p.586-594

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives

Journal of Child Neurology, 2011-11, Vol.26 (11), p.1411-1421

2011

Link zum Volltext

Verfügbarkeit prüfen

Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay

Journal of interferon & cytokine research, 2013-09, Vol.33 (9), p.523

2013

Link zum Volltext

Verfügbarkeit prüfen

Paraneoplastic movement disorders in childhood

Movement disorders, 2014-02, Vol.29 (2), p.281-281

2014

Link zum Volltext

Verfügbarkeit prüfen

Neuroimmunology of OMS and ANNA-1/anti-Hu paraneoplastic syndromes in a child with neuroblastoma

Neurology : neuroimmunology & neuroinflammation, 2018-03, Vol.5 (2), p.e433-e433

2018

Link zum Volltext

Verfügbarkeit prüfen

Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome

Journal of child neurology, 2012-07, Vol.27 (7), p.875-884

2012

Link zum Volltext

Verfügbarkeit prüfen

Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus

Pediatric blood & cancer, 2012-06, Vol.58 (6), p.988-991

2012

Link zum Volltext

Verfügbarkeit prüfen

Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies

Child neurology open, 2018, Vol.5, p.2329048X18795546

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome

Pediatrics (Evanston), 2005-01, Vol.115 (1), p.e115

2005

Link zum Volltext

Verfügbarkeit prüfen

An unusual presentation of anti‐Hu‐associated paraneoplastic limbic encephalitis

Developmental medicine and child neurology, 2012-09, Vol.54 (9), p.863-866

2012

Link zum Volltext

Verfügbarkeit prüfen

Acquired ataxias, infectious and para-infectious

Handbook of Clinical Neurology, 2012, Vol.103, p.137-146

2012

Link zum Volltext

Verfügbarkeit prüfen

Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome

Journal of pediatric hematology/oncology, 2006-09, Vol.28 (9), p.585-593

2006

Link zum Volltext

Verfügbarkeit prüfen

CCR4 Agonists CCL22 and CCL17 are Elevated in Pediatric OMS Sera: Rapid and Selective Down-Regulation of CCL22 by ACTH or Corticosteroids

Journal of clinical immunology, 2013-05, Vol.33 (4), p.817-825

2013

Link zum Volltext

Verfügbarkeit prüfen

CSF B-cell expansion in opsoclonus-myoclonus syndrome: A biomarker of disease activity

Movement disorders, 2004-07, Vol.19 (7), p.770-777

2004

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus

Neurology : neuroimmunology & neuroinflammation, 2017-03, Vol.4 (2), p.e316-e316

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Cerebrospinal Fluid and Blood Lymphocyte Dynamics After Rituximab for Pediatric Opsoclonus-Myoclonus

Journal of clinical immunology, 2010, Vol.30 (1), p.106-113

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(85)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines

Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study

Elevated cerebrospinal fluid C-X-C motif chemokine 10: Commonalities in paraneoplastic neurological disorders

BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy

B cell depletion therapy for new-onset opsoclonus-myoclonus

Response to Correspondence on “Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome”

Multifactorial analysis of opsoclonus‐myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children

Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping

Going with the flow: neuroinflammation

Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study

Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives

Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay

Paraneoplastic movement disorders in childhood

Neuroimmunology of OMS and ANNA-1/anti-Hu paraneoplastic syndromes in a child with neuroblastoma

Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome

Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus

Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies

Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome

An unusual presentation of anti‐Hu‐associated paraneoplastic limbic encephalitis

Acquired ataxias, infectious and para-infectious

Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome

CCR4 Agonists CCL22 and CCL17 are Elevated in Pediatric OMS Sera: Rapid and Selective Down-Regulation of CCL22 by ACTH or Corticosteroids

CSF B-cell expansion in opsoclonus-myoclonus syndrome: A biomarker of disease activity

Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus

Long-Term Cerebrospinal Fluid and Blood Lymphocyte Dynamics After Rituximab for Pediatric Opsoclonus-Myoclonus

Aktive Filter

Suchergebnisse filtern